Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particles

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 4, 2010, Pages 978-981

  Shebl, Fatma M ^a   Pinto, Ligia A ^b   García Piñeres, Alfonso ^b,d   Lempicki, Richard ^b   Williams, Marcus ^b   Harro, Clayton ^c   Hildesheim, Allan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN PAPILLOMAVIRUS 16 VACCINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER PREVENTION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION; VIRUS LIKE AGENT;

ADOLESCENT; ADULT; CAPSID PROTEINS; CLINICAL TRIALS, PHASE II AS TOPIC; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; PROTEINS; RNA, MESSENGER; YOUNG ADULT;

EID: 77950796618     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0064     Document Type: Article

References (24)

1. Hardiman G. Microarrays technologies 2006: an overview. Pharmacogenomics 2006;7:1153-1158
2. Melton L. Protein arrays: proteomics in multiplex. Nature 2004;429: 101-107
3. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-537 (Pubitemid 27174443)
4. Tian Q, Stepaniants SB, Mao M, et al. Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics 2004;3:960-969
5. Cox B, Kislinger T, Emili A. Integrating gene and protein expression data: pattern analysis and profile mining. Methods 2005;35:303-314 (Pubitemid 40255595)
6. de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein and mRNA expression levels. Mol Biosyst 2009;5: 1512-1526
7. Garcia-Pineres AJ, Hildesheim A, Dodd L, et al. Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients. J Immunol 2009;182:1706-1729
8. Garcia-Pineres A, Hildesheim A, Dodd L, et al. Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles. Clin Vaccine Immunol 2007;14:984-989
9. Pinto LA, Edwards J, Castle PE, et al. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16L1 virus-like particles. J Infect Dis 2003;188:327-338
10. Waghray A, Feroze F, Schober MS, et al. Identification of androgenregulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 2001 ;1:1327-1338
11. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002;1:304-313
12. Griffin TJ, Gygi SP, ldeker T, et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002;1:323-333
13. Lichtinghagen R, Musholt PB, Lein M, et al. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol 2002;42:398-406. (Pubitemid 35175803)
14. Mehra A, Lee KH, Hatzimanikatis V. Insights into the relation between mRNA and protein expression patterns: I. Theoretical considerations. Biotechnol Bioeng 2003;84:822-833
15. Nie L, Wu G, Zhang W. Correlation of mRNA expression and protein abundance affected by multiple sequence features related to transitional efficiency in Desulfovibrio vulgaris: a quantitative analysis. Genetics 2006;174:2229-2243
16. Shen L, Pili R. Posttranscription regulation of prostate cancer growth. Cancer J 2008;14:46-53.
17. Kozak M. Some thoughts about translational regulation: forward and backward glances. J Cell Biochem 2007;102:280-290 (Pubitemid 47519402)
18. Liu H, Bebu I, Li X. Microarray probes and probe sets. Front Biosci (Elite Ed) 2:325-338
19. Tan PK, Downey TJ, Spitznagel EL, Jr., et al. Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 2003;31:5676-5684
20. Hack C J. Integrated transcriptome and proteome data: the challenges ahead. Brief Funct Genomic Proteomic 2004;3:212-219
21. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP, Jr. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 2004;61:35-39
22. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 2009:10:52.
23. Djoba Siawaya JF, Roberts T, Babb C, et al. An evaluation of commercial fluorescent bead-based Luminex cytokine assays. PLoS One 2008;3:e2535.
24. Dallas PB, Gottardo NG, Firth MJ, et al. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative realtime RT-PCR-how well do they correlate? BMC Genomics 2005;6:59.